Related Experiment Video
Updated: Jul 15, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
[Mild cognitive impairment. Survey of attitudes of specialists and general physicians. mild]
Cecilia M Serrano1, Ricardo F Allegri, Paulo Caramelli
1LLaboratorio de Investigación de la Memoria del Hospital A. Zubizarreta (GCBA), Buenos Aires, Argentina. 2 siren@cemic.edu.ar
Abstract:
Mild cognitive impairment (MCI) refers to persons who are slightly cognitively impaired for age but do not meet the criteria for dementia. MCI has been related to a pre-dementia stage of Alzheimer's disease (AD). However, other possible diagnoses such as cerebro-vascular disease, frontotemporal dementia or normal aging have been considered. Diagnosis, etiology and conversion to dementia are a source of ambiguity in MCI. The aim was to evaluate the opinion of experts on dementia and of general practitioners concerning MCI. A total of 24 experts from Argentina and Brazil (16 neurologists and 8 psychiatrists) and 30 general practitioners agreed to reply to a questionnaire on MCI (adapted from Dubois inventory, 2003). Of these, 92% of experts considered MCI as an ambiguous entity, not necessarily as a "pre-dementia" stage; 63% confirmed a tendency to worsen over the time and 83% of experts decided to initiate treatment using cholinesterase inhibitors, memantine and vitamin E. The opinion on MCI was that a priori it is not only an Alzheimer disease pre-dementia stage, but most of them consider the treatment against AD. MCI is a heterogeneous entity that should be classified as an open category and making it necessary to standardize definitions and design diagnosis guides to better understand Alzheimer disease pre-dementia stage.
Insights
Mild cognitive impairment (MCI) is viewed as an ambiguous condition, not solely a pre-dementia stage of Alzheimer's disease (AD). Experts often initiate treatment for MCI, highlighting its complex nature and need for standardized diagnostic approaches.
Area of Science:
- Neurology
- Psychiatry
- Gerontology
Context:
- Mild cognitive impairment (MCI) is often considered a pre-dementia stage of Alzheimer's disease (AD).
- However, MCI can also be associated with cerebro-vascular disease, frontotemporal dementia, or normal aging.
- Diagnosis, etiology, and conversion to dementia present ambiguities in MCI.
Purpose:
- To evaluate the opinions of dementia experts and general practitioners regarding Mild Cognitive Impairment (MCI).
- To understand expert perspectives on MCI's nature, progression, and treatment.
Summary:
- A questionnaire assessing MCI opinions was distributed to 24 experts (neurologists, psychiatrists) and 30 general practitioners in Argentina and Brazil.
- 92% of experts viewed MCI as ambiguous, not exclusively a pre-dementia AD stage.
- 63% observed a tendency for MCI to worsen, and 83% initiated treatments like cholinesterase inhibitors, memantine, and vitamin E.
Impact:
- Findings suggest MCI is a heterogeneous entity requiring standardized definitions and diagnostic guides.
- Expert opinions indicate a need to broaden the understanding of MCI beyond just an Alzheimer's pre-dementia phase.
- This research highlights the clinical ambiguity surrounding MCI and the varied approaches to its management.
More Related Videos
Related Concept Videos
Dementia l: Introduction
Cognitive Development During Adulthood
Dementia
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

